CD68 and Patent ductus arteriosus: Principal component analysis was not able to distinguish these pathologies based on CD3+, CD8+ and CD68+ cell infiltrate (Fig 1bi), and while cluster analysis tended to group benign and premalignant disease in poorly infiltrated groups, there was not a clear classifier to distinguish PDA from other related pathologies (Fig 1bii).